FDA OKs Subcutaneous Daratumumab Plus VRd for Myeloma

Published Date: 05 Aug 2024

Indicated for newly diagnosed patients who are eligible for stem cell transplant

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

FDA OKs Subcutaneous Daratumumab Plus VRd for Myeloma

2.

Surgery may not be necessary to treat invasive breast cancer

3.

Radiation from CT scans could account for 5% of all cancer cases a year, study suggests

4.

FINAL USPSTF RECOMMENDATIONS ON ANXIETY, DEPRESSION, AND SUIICIDAL RISK.

5.

De-escalation Misses the Mark in Inflammatory Breast Cancer


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot